Sprague JE - Search Results

1

Genetic Variants Associated With Opioid Use Disorder.

Freiermuth CE, Kisor DF, Lambert J, Braun R, Frey JA, Bachmann DJ, Bischof JJ, Lyons MS, Pantalon MV, Punches BE, Ancona R, Sprague JE. Freiermuth CE, et al. Among authors: sprague je. Clin Pharmacol Ther. 2023 May;113(5):1089-1095. doi: 10.1002/cpt.2864. Epub 2023 Feb 19. Clin Pharmacol Ther. 2023. PMID: 36744646

2

Impact of common clandestine structural modifications on synthetic cathinone "bath salt" pharmacokinetics.

Grecco GG, Kisor DF, Magura JS, Sprague JE. Grecco GG, et al. Among authors: sprague je. Toxicol Appl Pharmacol. 2017 Aug 1;328:18-24. doi: 10.1016/j.taap.2017.05.010. Epub 2017 May 12. Toxicol Appl Pharmacol. 2017. PMID: 28506835

3

A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.

Calinski DM, Kisor DF, Sprague JE. Calinski DM, et al. Among authors: sprague je. Psychopharmacology (Berl). 2019 Mar;236(3):881-890. doi: 10.1007/s00213-018-4985-6. Epub 2018 Aug 1. Psychopharmacology (Berl). 2019. PMID: 30069588 Review.

4

Pharmacokinetic data of synthetic cathinones in female Sprague-Dawley rats.

Grecco GG, Kisor DF, Sprague JE. Grecco GG, et al. Among authors: sprague je. Data Brief. 2018 Oct 25;21:1045-1050. doi: 10.1016/j.dib.2018.10.073. eCollection 2018 Dec. Data Brief. 2018. PMID: 30450398 Free PMC article.

5

Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependence.

McCorkle ML, Kisor DF, Freiermuth CE, Sprague JE. McCorkle ML, et al. Among authors: sprague je. Pharmacogenomics. 2021 Aug;22(13):849-857. doi: 10.2217/pgs-2021-0023. Epub 2021 Aug 23. Pharmacogenomics. 2021. PMID: 34424051

6

HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education.

Ojeda MS, Chen AMH, Miracle T, Delaney E, Freiermuth CE, Sprague JE. Ojeda MS, et al. Among authors: sprague je. Subst Abuse Treat Prev Policy. 2022 Feb 7;17(1):10. doi: 10.1186/s13011-022-00436-8. Subst Abuse Treat Prev Policy. 2022. PMID: 35130945 Free PMC article.

7

The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder.

Banks ML, Sprague JE. Banks ML, et al. Among authors: sprague je. Addict Biol. 2024 Feb;29(2):e13369. doi: 10.1111/adb.13369. Addict Biol. 2024. PMID: 38380709 Free PMC article.

8

Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females.

Sprague JE, Freiermuth CE, Lambert J, Braun R, Frey JA, Bachmann DJ, Bischof JJ, Beaumont L, Lyons MS, Pantalon MV, Punches BE, Ancona R, Kisor DF. Sprague JE, et al. Pharmacogenomics J. 2024 Aug 1;24(4):23. doi: 10.1038/s41397-024-00337-y. Pharmacogenomics J. 2024. PMID: 39090078 Free PMC article.

9

Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys.

Banks ML, Sprague JE, Kisor DF, Czoty PW, Nichols DE, Nader MA. Banks ML, et al. Among authors: sprague je. Drug Metab Dispos. 2007 Oct;35(10):1840-5. doi: 10.1124/dmd.107.016261. Epub 2007 Jul 19. Drug Metab Dispos. 2007. PMID: 17640955

10

COVID-19 economic impact payments and opioid overdose deaths.

Sprague JE, Yeh AB, Lan Q, Vieson J, McCorkle M. Sprague JE, et al. Int J Drug Policy. 2022 Apr;102:103608. doi: 10.1016/j.drugpo.2022.103608. Epub 2022 Jan 31. Int J Drug Policy. 2022. PMID: 35131687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters